ER-POSITIVE BREAST CANCER

Refine Results:

News

Oncotype DX Cost Effective, Challenges Breast Cancer Practice

Elsevier Global Medical News, 2011 Dec 19, B Jancin

Breast Cancer Gene Profile Identifies Early vs Late Recurrences

Elsevier Global Medical News, 2011 Dec 7, K Wachter

Zoledronic Acid's Breast Cancer Benefit Extends 7 Years

Elsevier Global Medical News, 2011 Dec 7, D Mahoney

Everolimus Posts Big Win in ER-Positive Breast Cancer

Elsevier Global Medical News, 2011 Sept 27, P Wendling

EXPERT COMMENTARY

Score Predicts Late Recurrence in ER-Positive Breast Cancer

Elsevier Global Medical News, 2011 Sept 21, S London

More News ›

Journal Scans: Research

High Non-Compliance in the Use of Letrozole After 2.5 Years of Extended Adjuvant Endocrine Therapy. Results From the IDEAL Randomized Trial

Eur J Surg Oncol, 2012 Feb 1, DBY Fontein, et al

Neoadjuvant Anastrozole Versus Tamoxifen in Patients Receiving Goserelin for Premenopausal Breast Cancer (STAGE): A Double-Blind, Randomised Phase 3 Trial

Lancet Oncol, 2012 Jan 20, N Masuda, et al

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

N Engl J Med, 2011 Dec 7, J Baselga, et al

Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer

J Natl Cancer Inst, 2011 Dec 7, GM Monsees, et al

Influence of Histology on the Effectiveness of Adjuvant Chemotherapy in Patients With Hormone Receptor Positive Invasive Breast Cancer

Breast, 2011 Dec 1, W Truin, et al

More Journal Scans: Research ›

Journal Scans: Review

Cardiac Toxicity in Breast Cancer Patients: From a Fractional Point of View to a Global Assessment

Cancer Treat Rev, 2011 Jun 1, C Chargari, et al

Carnosol: A promising anti-cancer and anti-inflammatory agent

Cancer Lett, 2011 Jun 1, Jeremy J. Johnson

Preventive Therapy for Breast Cancer: A Consensus Statement

Lancet Oncol, 2011 May 1, J Cuzick, et al

Use of molecular markers for predicting therapy response in cancer patients

Cancer Treat Rev, 2011 Apr 1, Michael J. Duffy, et al

Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel

Cancer Treat Rev, 2011 Apr 1, O. Ortmann, et al

More Journal Scans: Review ›

Expert Opinion

Ask the Expert: Applying BOLERO-2 to the “Hormone-Refractory” Patient

2012 Jan 30, Clifford Hudis, et al

Ask the Expert: Best Treatment for Oligometastatic ER+ Breast Cancer

2012 Jan 30, Clifford Hudis, et al

Ask the Expert: After Mastectomy, What’s Next For DCIS?

2012 Jan 30, Clifford Hudis, et al

Dr. Clifford Hudis: 2011 Top Stories in Breast Cancer—Chemoprevention, Novel Agents, Less Surgery

Interview by L Scott Zoeller, 2012 Jan 24, Clifford Hudis, et al

An Update on Use of Bone-Directed Therapies in Patients With Cancer: Interview With Dr. Allan Lipton

OncologySTAT Editorial Team, 2011 Sept 21, L Scott Zoeller

More Expert Opinion ›